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Background
Huntsman Cancer Institute’s High-Risk Cancer Clinics
at the University of Utah has followed high-risk colon,
pancreatic, melanoma and breast cancer patients, under
the auspices of independently run and funded registries,
for over 15 years. As knowledge of the genetics of high-
risk syndromes and cancers has grown, awareness has
emerged of the clinical overlap between risks for these
conditions, previously viewed as distinct. To address this
growing understanding and to assist in the facilitation of
broad-based research efforts, we have embarked on a
plan to combine these registries into one single global
high-risk cancer registry.
Methods
The previously independent high-risk colon cancer
(~1,100 enrolled; > 1,300 blood and tissue samples) and
pancreatic cancer (242 enrolled; > 195 blood samples)
registries were merged into a single IRB-approved Her-
editary Gastrointestinal Cancer Registry (HGCR). This
merging of registries will take advantage of the known
clinical and genetic overlap between these two popula-
tions. Research records of participants automatically
rolled over into the new registry, therefore re-enroll-
ment was not mandatory. The combined registry enrolls
individuals and their family members with a personal
and/or family history of gastrointestinal cancer (GI) syn-
dromes and conditions, including those of the pancreas,
stomach, and colon as well as large kindreds with excess
cancers and unknown etiologies.
Results
The combined HGCR currently includes over 1,400
enrolled participants from ~400 kindreds. Over 1,500
DNA, cell lines, serum and tissue samples are available
for affiliated investigator use. Enrolled participants com-
plete personal, family and medical history questionnaires
and medical record releases and are asked to provide
blood/buccal and surgical tissue samples (where applic-
able). The HGCR supports multiple types of basic and
translational research projects, including two chemopre-
vention trials for Peutz-Jeghers patients (ongoing) and
FAP patients (pending), psychosocial assessments in
high-risk cancer families, and multiple molecular studies
for mutation identification methods. Family expansion
efforts are focused on expanding populations eligible for
registry-supported studies. Substantial progress has been
made in collecting and abstracting medical records of
cancers and GI procedures. More than 800 medical
record procedures, including available genetic test
results, have been abstracted since the launch of the
new registry. Increases in participant referrals to and
from genetic counselors, health-care providers and eligi-
ble research studies (internally and externally) have been
noted and are expected to increase considerably over
time.
Conclusions
Since the successful amalgamation of the colon and
pancreatic registries into a single registry, we recognize
the necessity and feasibility for combining additional
high-risk registries into a large global cancer registry.
Future plans include integrating with our high-risk
melanoma and breast cancer registries.
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